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COMMENTARY
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Abstract 
A growing multitude of known genetic diagnoses can result in presentation to child psychiatry. For numerous rea‑
sons, it is important to identify a genetic etiology in child psychiatry patients when it is present. Genetic diagnoses 
can guide treatment and enable access to specialized clinics and appropriate screening measures. They can also allow 
for genetic counseling for the patient and family. A better understanding of etiology with a named diagnosis can 
itself be of great value to many patients and families; prognostic information can be empowering. Since patients with 
genetic conditions may present to psychiatric care in diverse ways, child psychiatrists must decide who to refer for 
genetic evaluation. Here we create a table to provide a framework of concerning/notable history and exam features 
that a practicing child psychiatrist may encounter that should prompt one to consider whether a larger, unifying 
genetic diagnosis is at hand. We hope this framework will facilitate referral of child psychiatry patients to genetics so 
that more patients can benefit from an appropriate diagnosis.
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Background
A growing multitude of known genetic diagnoses can 
result in presentation to child psychiatry. The prevalence 
of genetic diagnoses among child psychiatry patients is 
best studied for autism, where 10–20  % of cases have a 
diagnosable genetic cause [e.g. Fragile X (FXS)] [1–6]. 
There is little information about the prevalence of genetic 
conditions in child psychiatry patients more gener-
ally. There are a large number of different genetic con-
ditions that may lead to psychiatric presentation in a 
child. A December 2015 search of the Online Mendelian 
Inheritance in Man database (OMIM.org®), a catalog 
of genetic conditions, reveals 42 genetic etiologic asso-
ciations for both psychiatric symptoms and autism. As 
genetic understanding continues to progress, the overlap 
with child psychiatry grows and it becomes increasingly 
important for child psychiatrists to recognize signs of a 
possible underlying genetic diagnoses [7].
In some instances, a genetic condition may have a typi-
cal psychiatric presentation and psychiatric symptoms 
may appear isolated. In such cases, presentation may 
be indistinguishable from that of a typical psychiatric 
patient whose disease is polygenic and multifactorial and 
genetic diagnosis is more difficult [8]. However, in many 
cases a genetic etiology may be suggested by features of 
history or physical exam. If child psychiatrists are aware 
of red flags signifying possible genetic condition, more 
patients can be appropriately diagnosed.
This article addresses two questions: Why is it impor-
tant to diagnose genetic conditions in child psychiatry 
patients? What should prompt a child psychiatrist to 
request a genetic consult for a patient?
Main text
Benefits of diagnosing genetic conditions
Identifying a genetic etiology in child psychiatry patients 
has many benefits [9]. Diagnosis of specific genetic con-
ditions can guide treatment and allow access to special-
ized healthcare. For example, depression may herald 
Wilson disease, which can be effectively treated with che-
lators [10]. In metabolic disorders with psychiatric symp-
toms, a diagnosis can allow for appropriate management 
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to avoid metabolic decompensations, which worsen both 
psychiatric and somatic symptoms [8]. In children with 
FXS, hyperactivity responds particularly well to methyl-
phenidate. Hyperactivity is more responsive to methyl-
phenidate as part of FXS versus part of autism spectrum 
disorder or intellectual disability, or possibly even non-
specific ADHD [3]. When diagnosed, these patients can 
be put directly on methylphenidate and avoid many med-
ication trials, which carry associated risks. Furthermore, 
because psychiatric symptoms may arise years before 
more specific organic signs, certain treatments may be 
more effective at the ‘psychiatric stage’ before occurrence 
of irreversible lesions. This is particularly true for meta-
bolic disorders [11]. Genetic diagnosis also enables access 
to specialized clinics with greater understanding of and 
experience with these complex presentations [12]. There 
are a growing number of condition-specific and neuro-
genetic clinics that may be very beneficial to patients. 
Because wait times to appointments can be challeng-
ing, other consultation strategies (e.g. telehealth) may be 
considered.
Additionally, some genetic conditions are associated 
with known medical complications and may require rou-
tine screening or further medical work-up. For example, 
a patient presenting with autism spectrum disorder and 
macrocephaly who is found to have a PTEN mutation can 
then be enrolled in a cancer screening protocol. Further, 
diagnosis can allow for appropriate genetic counseling 
for the patient and family [12, 13].
Finally, a better understanding of etiology with a named 
diagnosis may itself be of great value to many. Most indi-
viduals would rather know they have a serious disease 
than continue without a diagnosis [14]. Diagnosis allows 
for improved understanding, educational planning, and 
social support, and peer networking [15, 16]. Prognostic 
information can be empowering.
Indications for genetic consultation
It is not practical to conduct a genetic workup on all 
patients, so child psychiatrists must decide whom to 
refer for genetic evaluation [1]. Child psychiatrists are in 
an important position to diagnose genetic conditions, as 
they often see children for whom a diagnosis has been 
elusive, who have unusual presentations, or who have 
been difficult to treat.
Patients with genetic conditions may present to psy-
chiatric care in diverse ways. Table 1 shows genetic con-
ditions that may in rare cases account for typical child 
psychiatry presentations. Psychiatric symptoms may be 
apparently isolated, making genetic diagnosis difficult. 
However, often a careful history and physical provides 
hints to a genetic diagnosis.
Some unusual psychiatric presentations or behaviors 
may suggest a particular genetic etiology. Skin picking 
may occur in Prader-Willi syndrome [25] while severe 
disruptions of sleep and nail pulling suggest Smith-
Magenis syndrome [26]. In many cases, non-psychiat-
ric features of the history or exam will provide clues to 
genetic etiology.
The purpose of Table  2 is to present a framework of 
notable history and exam features that should prompt a 
child psychiatrist to consider whether there is a larger, 
unifying genetic diagnosis at hand. All of these features 
are recognized as markers in pediatric genetic practice, 
however here the goal is to isolate the flags most likely 
to present in a child psychiatry practice [27]. This table 
is just a starting point and should not be considered 
exhaustive.
If one or more of these red flags are present, a child 
psychiatrist should consider requesting a genetic con-
sultation. Whenever possible, genetic tests should be 
ordered in conjunction with a genetic team. On a prac-
tical level, determining which genetic tests to order 
can be confusing and outside the usual practice of 
most child psychiatrists. Even more important, many 
child psychiatrists are not comfortable explaining the 
intricacies of genetic testing and lack the infrastruc-
ture to deal with ramifications of positive results [28]. 
Informed consent must include discussion of the risks 
of genetic testing, which include harms associated with 
Table 1 Genetic syndromes may in rare cases manifest in more general child psychiatry presentations
Psychiatric presentation Example of genetic syndrome that may result in this presentation
Anxiety 22q11 deletion [17], Fragile X syndrome [18], Williams syndrome [19]
Acute psychosis Adrenoleukodystrophy [20], Porphyria [21], Niemann‑Pick [21], 22q11 deletion [17]
Conduct disorder/poor judgment/anger Monoamine oxidase A deficiency [22]
Hyperactivity Turner syndrome [23], Fragile X syndrome [3]
Depression Wilson disease [24]
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resultant treatments and incidental findings that can be 
life changing or psychologically disruptive [29]. There 
may be particular cases in which a child psychiatrist has 
experience with or training relevant to a certain genetic 
test and feels comfortable ordering this test, so this 
remains an individual call. However, in most cases it is 
best to involve a genetic team and employ their associ-
ated infrastructure. It is our hope that this table will help 
child psychiatrists communicate with genetic teams by 
allowing them to pinpoint the red flags that led them to 
consider a genetic etiology.
Conclusions
It is important to identify a genetic etiology in child psy-
chiatry patients when it is present, as it has implications 
for treatment and counseling. Patients with genetic 
conditions may have unusual psychiatric symptoms or 
other abnormal history and physical findings. Here we 
present a table of red flags that a practicing child psy-
chiatrist may identify, which could indicate an under-
lying genetic diagnosis. We hope this table will inspire 
child psychiatrists to think about genetic possibili-
ties in their patient populations and make referrals for 
genetic evaluation when appropriate. Future work will 
be needed to validate this table in practice. However, 
being aware of these the flags has immediate utility in 
the clinical practice of child psychiatrists. To highlight 
how simple practice changes may have a big impact for 
diagnosing conditions, we provide a short list of tips 
and resources for making a genetic diagnosis in child 
psychiatry (Table  3). We hope that this commentary 
will encourage child psychiatrists to think about their 
growing overlap with the field of genetics. Recognition 
of the importance of genetic diagnoses in child psychia-
try patients may stimulate more research into the preva-
lence of genetic disease, effective methods of screening 
and diagnosis, and strategies for treatment and manage-
ment for these patients.
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